Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.88 USD | +0.31% | +14.65% | -13.60% |
04-26 | Belite Bio Unveils Plan to Offer 651,380 American Depository Shares | MT |
03-22 | Belite Bio Completes Regulatory Submission for Tinlarebant's Clinical Trial in Japan | MT |
Sales 2024 * | 10M 13.65M | Sales 2025 * | 6.25M 8.53M | Capitalization | 1.16B 1.58B |
---|---|---|---|---|---|
Net income 2024 * | -22M -30.03M | Net income 2025 * | -25M -34.13M | EV / Sales 2024 * | 110 x |
Net cash position 2024 * | 63.14M 86.2M | Net cash position 2025 * | 40.52M 55.31M | EV / Sales 2025 * | 179 x |
P/E ratio 2024 * |
-51.9
x | P/E ratio 2025 * |
-48.3
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 19.31% |
Latest transcript on Belite Bio, Inc
1 day | +0.31% | ||
1 week | +14.65% | ||
Current month | +3.02% | ||
1 month | +7.10% | ||
3 months | -13.18% | ||
6 months | +3.51% | ||
Current year | -13.60% |
Managers | Title | Age | Since |
---|---|---|---|
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 18-03-26 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 20-10-31 |
Nathan L. Mata
CTO | Chief Tech/Sci/R&D Officer | 58 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 22-03-31 | |
Yi Ta Lue
BRD | Director/Board Member | 47 | 22-03-31 |
John Longo
BRD | Director/Board Member | 55 | 22-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +1.52% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 39.53 | -0.55% | 7 546 |
24-04-26 | 39.75 | +4.61% | 46,599 |
24-04-25 | 38 | +1.96% | 16,035 |
24-04-24 | 37.27 | +0.73% | 32,733 |
24-04-23 | 37 | +7.31% | 38,820 |
Delayed Quote Nasdaq, April 29, 2024 at 01:49 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.60% | 1.16B | |
+2.45% | 42.75B | |
+47.70% | 41.61B | |
+11.88% | 41.34B | |
-8.83% | 26.59B | |
+7.16% | 25.49B | |
-22.67% | 18.12B | |
+30.83% | 12.24B | |
-1.99% | 11.76B | |
+9.22% | 11B |
- Stock Market
- Equities
- BLTE Stock